TD Cowen analyst Steven Mah maintained a Buy rating on Rapid Micro Biosystems (RPID – Research Report) today. The company’s shares opened today at $1.00.
Mah covers the Healthcare sector, focusing on stocks such as BioLife Solutions, Twist Bioscience, and Codexis. According to TipRanks, Mah has an average return of -8.6% and a 31.50% success rate on recommended stocks.
Rapid Micro Biosystems has an analyst consensus of Moderate Buy.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $1.55 and a one-year low of $0.74. Currently, Rapid Micro Biosystems has an average volume of 190.3K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Rapid Micro Biosystems (RPID) Company Description:
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company’s flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
Read More on RPID:
- Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
- Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System
- Rapid Micro announces Samsung Biologics selected its Growth Direct platform
- Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
- Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
